These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Mutational analysis of the androgen receptor AF-2 (activation function 2) core domain reveals functional and mechanistic differences of conserved residues compared with other nuclear receptors. Slagsvold T, Kraus I, Bentzen T, Palvimo J, Saatcioglu F. Mol Endocrinol; 2000 Oct; 14(10):1603-17. PubMed ID: 11043576 [Abstract] [Full Text] [Related]
8. Domain interactions between coregulator ARA(70) and the androgen receptor (AR). Zhou ZX, He B, Hall SH, Wilson EM, French FS. Mol Endocrinol; 2002 Feb; 16(2):287-300. PubMed ID: 11818501 [Abstract] [Full Text] [Related]
9. Distinct recognition modes of FXXLF and LXXLL motifs by the androgen receptor. Dubbink HJ, Hersmus R, Verma CS, van der Korput HA, Berrevoets CA, van Tol J, Ziel-van der Made AC, Brinkmann AO, Pike AC, Trapman J. Mol Endocrinol; 2004 Sep; 18(9):2132-50. PubMed ID: 15178743 [Abstract] [Full Text] [Related]
10. Interaction between the amino- and carboxyl-terminal regions of the rat androgen receptor modulates transcriptional activity and is influenced by nuclear receptor coactivators. Ikonen T, Palvimo JJ, Jänne OA. J Biol Chem; 1997 Nov 21; 272(47):29821-8. PubMed ID: 9368054 [Abstract] [Full Text] [Related]
11. Androgen receptor ligand-binding domain interaction and nuclear receptor specificity of FXXLF and LXXLL motifs as determined by L/F swapping. Dubbink HJ, Hersmus R, Pike AC, Molier M, Brinkmann AO, Jenster G, Trapman J. Mol Endocrinol; 2006 Aug 21; 20(8):1742-55. PubMed ID: 16627595 [Abstract] [Full Text] [Related]
12. Functional analysis of a novel androgen receptor mutation, Q902K, in an individual with partial androgen insensitivity. Umar A, Berrevoets CA, Van NM, van Leeuwen M, Verbiest M, Kleijer WJ, Dooijes D, Grootegoed JA, Drop SL, Brinkmann AO. J Clin Endocrinol Metab; 2005 Jan 21; 90(1):507-15. PubMed ID: 15486055 [Abstract] [Full Text] [Related]
14. Ligand- and coactivator-mediated transactivation function (AF2) of the androgen receptor ligand-binding domain is inhibited by the cognate hinge region. Wang Q, Lu J, Yong EL. J Biol Chem; 2001 Mar 09; 276(10):7493-9. PubMed ID: 11102454 [Abstract] [Full Text] [Related]
16. The use of androgen receptor amino/carboxyl-terminal interaction assays to investigate androgen receptor gene mutations in subjects with varying degrees of androgen insensitivity. Ghali SA, Gottlieb B, Lumbroso R, Beitel LK, Elhaji Y, Wu J, Pinsky L, Trifiro MA. J Clin Endocrinol Metab; 2003 May 09; 88(5):2185-93. PubMed ID: 12727974 [Abstract] [Full Text] [Related]
17. Evidence for an anti-parallel orientation of the ligand-activated human androgen receptor dimer. Langley E, Zhou ZX, Wilson EM. J Biol Chem; 1995 Dec 15; 270(50):29983-90. PubMed ID: 8530400 [Abstract] [Full Text] [Related]
18. The androgen receptor amino-terminal domain plays a key role in p160 coactivator-stimulated gene transcription. Alen P, Claessens F, Verhoeven G, Rombauts W, Peeters B. Mol Cell Biol; 1999 Sep 15; 19(9):6085-97. PubMed ID: 10454556 [Abstract] [Full Text] [Related]
19. Roles of steroid receptor coactivator (SRC)-1 and transcriptional intermediary factor (TIF) 2 in androgen receptor activity in mice. Ye X, Han SJ, Tsai SY, DeMayo FJ, Xu J, Tsai MJ, O'Malley BW. Proc Natl Acad Sci U S A; 2005 Jul 05; 102(27):9487-92. PubMed ID: 15983373 [Abstract] [Full Text] [Related]
20. An investigation into CAG repeat length variation and N/C terminal interactions in the T877A mutant androgen receptor found in prostate cancer. Southwell J, Chowdhury SF, Gottlieb B, Beitel LK, Lumbroso R, Purisima EO, Trifiro M. J Steroid Biochem Mol Biol; 2008 Jul 05; 111(1-2):138-46. PubMed ID: 18619542 [Abstract] [Full Text] [Related] Page: [Next] [New Search]